Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1124.8000 -12.00 (-1.06%)
NSE Oct 14, 2025 15:31 PM
Volume: 1.0M
 

logo
Aurobindo Pharma Ltd.
28 May 2024
1124.80
-1.06%
buy
by BOB Capital Markets Ltd.
Target: 1200
BOB Capital Markets Ltd.
ARBP: Strong quarter; OAI at Eugia-III an overhang. CPBI: In-line quarter; weak near-term outlook
 
Number of FII/FPI investors decreased from 728 to 700 in Sep 2025 qtr
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower, ICICI Prudential's Q2 revenue falls 52% YoY
Trendlyne Marketwatch | 14 Oct 2025, 04:05PM
IPO market cools: LG Electronics, Canara Robeco, plus seven listings, and a new issue
| 13 Oct 2025, 04:01PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020